Glenmark Pharmaceuticals will pay $25 million to settle a case with the US Department of Justice related to generic drug pricing. The settlement, announced late Wednesday, will be paid by Glenmark Pharmaceuticals
Mankind Pharma Ltd, the fourth-largest pharmaceutical company in India, is gearing up to raise over ₹9,000 crore through a combination of non-convertible debentures (NCDs) and short-term commercial paper. This move is part
Shares of Marksans Pharma surged 16% to a record high of ₹217 in Wednesday’s trading on the BSE, driven by impressive financial results for the June 2024 quarter (Q1FY25). The stock hit
Sun Pharmaceutical Industries Ltd’s new alopecia treatment, Leqselvi (Deuruxolitinib), recently approved by the US Food and Drug Administration (FDA), is encountering legal challenges that may delay its market debut. A motion for
